Observational studyBMC cardiovascular disorders2026
Clinical value of RT-3DE in evaluating mitral valve configuration and the occurrence of VFMR in patients with ischemic cardiomyopathy: a clinical investigation.
Observational study in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study used real-time three-dimensional echocardiography (RT-3DE) to obtain three-dimensional (3D) geometric parameters of the mitral annulus and leaflets, including annular structural indices, leaflet angles, and tenting volume (VTent). We further compared the remodeling patterns between atrial functional mitral regurgitation (AFMR) and ventricular functional mitral regurgitation (VFMR). In addition, RT-3DE combined with speckle tracking imaging (STI) was applied to evaluate structural and functional changes of the left ventricular (LV) and mitral valve (MV) in patients with ischemic cardiomyopathy (ICM) and to identify factors associated with VFMR.
methodsIn this cross-sectional observational imaging study, 143 patients diagnosed with ICM admitted between July 2022 and November 2023 were enrolled and classified into a VFMR group (n = 68) and a non-VFMR group (n = 75). Another 53 patients with AFMR and 50 healthy controls were also recruited. MV geometry and LV strain parameters were measured via RT-3DE and STI. Multivariable logistic regression analysis was performed to identify the independent predictors of VFMR.
resultsCompared with healthy controls, patients with AFMR and VFMR had reduced left ventricular ejection fraction (LVEF), increased LV volumes, and enlarged left atrial diameter. Patients with VFMR presented higher levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG). Both functional mitral regurgitation (FMR) subtypes showed significant alterations in mitral annular and leaflet geometry, with VFMR demonstrating greater annular circularity and VTent. Impaired global longitudinal strain (GLS), reduced LV twist, and increased mitral VTent were identified as independent predictors of VFMR. The combined model incorporating these parameters yielded an area under the curve (AUC) of 0.814, indicating moderate predictive performance.
conclusionRT-3DE allows non-invasive evaluation of mitral annular and leaflet geometry and facilitates objective comparison of remodeling patterns between AFMR and VFMR. AFMR is characterized by a larger posterior leaflet angulation, whereas VFMR exhibits more pronounced annular circularity and leaflet tenting. In patients with ICM, impaired LV longitudinal strain, reduced LV twist, and increased VTent are independent factors associated with VFMR. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.